Skip to main content
Sarah O'Shea, MD, Neurology, New York, NY

SarahAnnO'SheaMDMS

Neurology New York, NY

Movement Disorder, Dementia & Geriatrics

Assistant Professor of Neurology

Overview of Dr. O'Shea

Dr. Sarah O'Shea is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from University of Illinois College of Medicine at Chicago and has been in practice 5 years. She also speaks multiple languages, including Spanish. She specializes in movement disorder and dementia & geriatrics and is experienced in deep brain stimulation, movement disorders, parkinson's disease, epidemiology, and botulinum toxin injections for movement disorders. She has more than 20 publications and over 150 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Neuromuscular Medicine (Neurology), 2016 - 2019
  • Columbia University
    Columbia University MS, Epidemiology, 2016 - 2018
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Neurology, 2012 - 2016
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2012

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2025
  • MA State Medical License
    MA State Medical License 2019 - 2023
  • IA State Medical License
    IA State Medical License 2012 - 2016
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Development of Hypertrophic Olivary Degeneration Following Pontine Hemorrhage.
    Bird K, Saint-Hilaire M, Curiale G, O'Shea SA., The International Parkinson and Movement Disorder Society (MDS) Congress., Virtual, 2020
  • The Accreditation and Certification of the Movement Disorders Subspecialty: A Five- Year Follow-Up Study.
    S. O’Shea, L. Guttmann, L. Faulkner., The International Parkinson and Movement Disorder Society (MDS) Congress., Virtual, 2020
  • Prenatal Exposure to Chlorpyrifos and Parkinson’s risk: a prospective adolescent cohort evaluation.
    O’Shea SA, Alcalay R, Rauh V., American Academy of Neurology (AAN), Los Angeles, CA, 2018
  • Join now to see all

Press Mentions

  • Parkinson's Disease Foundation Announces $4 Million in Research Investments to Solve, Treat and End Parkinson's Disease
    Parkinson's Disease Foundation Announces $4 Million in Research Investments to Solve, Treat and End Parkinson's DiseaseJune 9th, 2016

Other Languages

  • Spanish